Weekly Insulin Shot Could Be a Game Changer for Those With Type 2 Diabetes
MONDAY, July 17, 2023 (HealthDay News) — People with type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required.A once-weekly insulin formulation called icodec performed just as…
Learn MoreDiabetes Medications: Choosing Which Ones Are Best for You
WEDNESDAY, July 5, 2023 (HealthDay News) — You have been diagnosed with type 2 diabetes. What are your medication options?That depends on what type of diabetes you have and what risk factors you carry.In type 2 diabetes, the body becomes resistant to…
Learn More¿Toma Ozempic o Wegovy? Pare antes de una cirugía, aconsejan anestesiólogos
LUNES, 3 de julio de 2023 (HealthDay News) — Ozempic, el medicamento de moda para perder peso, podría ser peligroso para un paciente que se somete a anestesia para una cirugía, según una nueva advertencia de la Sociedad Americana de Anestesiólogos (A…
Learn MoreTaking Ozempic, Wegovy? Stop Before Surgery, Anesthesiologists Say
MONDAY, July 3, 2023 (HealthDay News) — The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists.Semaglutide (Ozempic, Wegov…
Learn MoreUnos nuevos fármacos para perder peso se preparan para competir con Ozempic y Wegovy
LUNES, 26 de junio de 2023 (HealthDay News) — Después de que la compañía farmacéutica Novo Nordisk modificara su medicamento Ozempic para convertirlo en Wegovy, una formulación diseñada de forma expresa para ayudar a los usuarios a bajar de peso, las…
Learn MoreNew Drugs Line Up to Challenge Ozempic, Wegovy for Weight Loss
MONDAY, June 26, 2023 (HealthDay News) — After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy — a formulation expressly designed to help users shed pounds — sales of both drugs skyrocketed.Other pharmaceutical giants took notice…
Learn MoreNovo Nordisk busca impedir que las empresas vendan versiones compuestas de Wegovy y Ozempic
MIÉRCOLES, 21 de junio de 2023 (HealthDay News) — El fabricante de tres medicamentos populares que tratan la pérdida de peso y la diabetes anunció el martes que ha iniciado un proceso legal contra las empresas que venden versiones compuestas (también…
Learn MoreNovo Nordisk Moves to Stop Businesses From Selling Compounded Versions of Wegovy, Ozempic
WEDNESDAY, June 21, 2023 (HealthDay News) – The maker of three popular drugs that treat weight loss and diabetes said Tuesday that it has begun legal proceedings against businesses that are selling compounded versions of its products that are not appr…
Learn MoreLa metformina, un fármaco para la diabetes, podría ayudar a prevenir la COVID prolongada
VIERNES, 9 de junio de 2023 (HealthDay News) — Una pastilla genérica y segura para la diabetes puede ayudar a las personas a evitar la COVID prolongada, muestra un nuevo ensayo clínico. La metformina redujo el riesgo de COVID prolongada en alrededor …
Learn MoreDiabetes Med Metformin Might Help Prevent Long COVID
FRIDAY, June 9, 2023 (HealthDay News) — A safe, generic diabetes pill can help people avoid long COVID, a new clinical trial shows.Metformin cut the risk of long COVID by about 40% for patients who received a two-week course of the drug while battlin…
Learn More